ID   RUCDRi002-A-65
AC   CVCL_D6N2
SY   LVIP05-RB1-CS3; RB1-CS3; LVPEIi003-A-65
DR   BioSamples; SAMEA115170104
DR   hPSCreg; RUCDRi002-A-65
RX   PubMed=38452707;
CC   Population: Hispanic.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 9884; RB1 (Note=Disrupted at exon 18).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=38452707; DOI=10.1016/j.scr.2024.103373;
RA   Agrawal T., Maddileti S., Mariappan I.;
RT   "Generation and characterization of three CRISPR/Cas9 edited RB1 null
RT   hiPSC lines for retinoblastoma disease modelling.";
RL   Stem Cell Res. 76:103373-103373(2024).
//